lobbying_activities: 2875164

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2875164	b8e96f5f-d45c-473c-977f-ad7651d15b9c	Q3	RAMPY NORTHRUP LLC	401103289	NATURAL PRODUCTS ASSOCIATION	2022	third_quarter	FOO	FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2022-10-19T11:26:48-04:00